Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet Injector
Clinical trial NCT01765426 · COMPLETED
Trial details
- NCT number
- NCT01765426
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-15
- Primary completion
- 2014-06-26
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.